Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03221426 |
|---|---|
| Brief Title: | Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585) |
| First Submitted : | July 17, 2017 |
| First Submitted that Met QC Criteria : | July 17, 2017 |
| First Posted : | July 18, 2017 |
| Last Update Submitted that Met QC Criteria : | May 5, 2024 |
| Last Update Posted : | May 7, 2024 |